| # | Drug | Count |
|---|---|---|
| 0 | ACETAMINOPHEN | 3 |
| 1 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 3 |
| 2 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 3 |
| 3 | CAPECITABINE | 3 |
| 4 | CETIIRIZINE | 3 |
| 5 | CETIRIZINE | 3 |
| 6 | CETIRIZINE HYDROCHLORIDE | 3 |
| 7 | ROSUVASTATIN | 3 |
| 8 | EPOPROSTENOL | 2 |
| 9 | OXALIPLATIN | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-ARGININE | 1 | 0.0028 |
| 1 | GEMCITABINE INTRAVESICAL | 1 | 0.0021 |
| 2 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 3 | EPOPROSTENOL | 2 | 0.0002 |
| 4 | METHIMAZOLE | 1 | 0.0001 |
| 5 | METOLAZONE | 1 | 0.0001 |
| 6 | CETIIRIZINE | 3 | 0.0001 |
| 7 | ROPINIROLE | 1 | 0.0001 |
| 8 | ROSUVASTATIN | 3 | 0.0000 |
| 9 | CAPECITABINE | 3 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 5 |
| 1 | Expectorant [EPC] | 3 |
| 2 | Histamine-1 Receptor Antagonist [EPC] | 3 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 3 |
| 4 | Osmotic Laxative [EPC] | 2 |
| 5 | Platinum-based Drug [EPC] | 2 |
| 6 | Potassium Salt [EPC] | 2 |
| 7 | Prostacycline Vasodilator [EPC] | 2 |
| 8 | Cardiac Glycoside [EPC] | 1 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 1 | Nonergot Dopamine Agonist [EPC] | 1 | 0.0001 |
| 2 | Histamine-1 Receptor Antagonist [EPC] | 3 | 0.0000 |
| 3 | Thiazide-like Diuretic [EPC] | 1 | 0.0000 |
| 4 | Macrolide Antimicrobial [EPC] | 1 | 0.0000 |
| 5 | Prostacycline Vasodilator [EPC] | 2 | 0.0000 |
| 6 | Expectorant [EPC] | 3 | 0.0000 |
| 7 | Cardiac Glycoside [EPC] | 1 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Fluoroquinolone Antibacterial [EPC] | 1 | 0.0000 |